Literature DB >> 686045

Problems encountered in the treatment of pregnancy-induced hypertension. A point of view.

F P Zuspan.   

Abstract

This point of view encountered in the treatment of pregnancy-induced hypertension enumerates the most common problems encountered when treating the disease. These problems include: terminology, etiology and pathogenesis, known facts, failure to identify the patient, loss of life for mother and baby, complications, recognition of early disease, and treatment not uniform or individualized. The severe forms of the disease are preventable and should never occur, but once present they should yield a zero maternal mortality rate and a fetal salvage of greater than 90%. Proper therapy of severe disease is primarily the use of pharmacologic doses of magnesium sulfate given intravenously and the prevention of a cerebral vascular accident in the mother. Induction of labor and removal of the products of conception will cure the disease.

Entities:  

Mesh:

Year:  1978        PMID: 686045     DOI: 10.1016/0002-9378(78)90816-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 2.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 3.  Magnesium sulphate versus lytic cocktail for eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 4.  Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; David J Henderson-Smart; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

Review 5.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.

Authors:  Lelia Duley; Hosam E Matar; Muhammad Qutayba Almerie; David R Hall
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

6.  Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial.

Authors:  Carlos Noronha Neto C; Sabina S B Maia; Leila Katz; Isabela C Coutinho; Alex R Souza; Melania M Amorim
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.

Authors:  Sara Houlihan; Diane Decarie; Cindy Benes; Richard Cleve; Marianne Vidler; Laura A Magee; Mary H H Ensom; Peter von Dadelszen
Journal:  J Obstet Gynaecol Can       Date:  2016-06-29

8.  Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.

Authors:  Lihong Du; Larissa Wenning; Elizabeth Migoya; Yan Xu; Brendan Carvalho; Kathleen Brookfield; Han Witjes; Rik de Greef; Pisake Lumbiganon; Ussanee Sangkomkamhang; Vitaya Titapant; Lelia Duley; Qian Long; Olufemi T Oladapo
Journal:  J Clin Pharmacol       Date:  2018-11-13       Impact factor: 3.126

9.  Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.

Authors:  Bissallah A Ekele; Danjuma Muhammed; Lawal N Bello; Ibrahim M Namadina
Journal:  BMC Res Notes       Date:  2009-08-19

10.  Clonidine versus captopril for treatment of postpartum very high blood pressure: study protocol for a randomized controlled trial (CLONCAP).

Authors:  Carlos Noronha-Neto; Leila Katz; Isabela C Coutinho; Sabina B Maia; Alex Sandro Rolland Souza; Melania Maria Ramos Amorim
Journal:  Reprod Health       Date:  2013-07-30       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.